First National Bank Of Omaha Supernus Pharmaceuticals, Inc. Transaction History
First National Bank Of Omaha
- $1.43 Billion
- Q2 2024
A detailed history of First National Bank Of Omaha transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, First National Bank Of Omaha holds 10,414 shares of SUPN stock, worth $379,069. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,414
Previous 12,115
14.04%
Holding current value
$379,069
Previous $413,000
32.69%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding SUPN
# of Institutions
264Shares Held
59.4MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$378 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$223 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$192 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$105 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$97.5 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.95B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...